These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33200115)

  • 1. Tuning Proton Transfer Thermodynamics in SARS-Cov-2 Main Protease: Implications for Catalysis and Inhibitor Design.
    Zanetti-Polzi L; Smith MD; Chipot C; Gumbart JC; Lynch DL; Pavlova A; Smith JC; Daidone I
    ChemRxiv; 2020 Nov; ():. PubMed ID: 33200115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.
    Zanetti-Polzi L; Smith MD; Chipot C; Gumbart JC; Lynch DL; Pavlova A; Smith JC; Daidone I
    J Phys Chem Lett; 2021 May; 12(17):4195-4202. PubMed ID: 33900080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design.
    Yu W; Wu X; Zhao Y; Chen C; Yang Z; Zhang X; Ren J; Wang Y; Wu C; Li C; Chen R; Wang X; Zheng W; Liao H; Yuan X
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg
    Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS
    J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depicting the inhibitory potential of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2022 Apr; 40(6):2647-2662. PubMed ID: 33140695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease.
    Ngo ST; Quynh Anh Pham N; Thi Le L; Pham DH; Vu VV
    J Chem Inf Model; 2020 Dec; 60(12):5771-5780. PubMed ID: 32530282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering inhibitory activity of marine algae Ecklonia cava phlorotannins against SARS CoV-2 main protease: A coupled in-silico docking and molecular dynamics simulation study.
    Chakraborty A; Ghosh R; Barik S; Mohapatra SS; Biswas A; Chowdhuri S
    Gene; 2024 Oct; 926():148620. PubMed ID: 38821329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay.
    Stewart J; Shawon J; Ali MA; Williams B; Shahinuzzaman ADA; Rupa SA; Al-Adhami T; Jia R; Bourque C; Faddis R; Stone K; Sufian MA; Islam R; McShan AC; Rahman KM; Halim MA
    J Pept Sci; 2024 Apr; 30(4):e3553. PubMed ID: 38031661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.
    Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA
    Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor.
    Nashed NT; Aniana A; Ghirlando R; Chiliveri SC; Louis JM
    Commun Biol; 2022 Mar; 5(1):160. PubMed ID: 35233052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of alkaloids from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Mol Struct; 2021 Apr; 1229():129489. PubMed ID: 33100380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro
    Ngo ST; Nguyen TH; Tung NT; Vu VV; Pham MQ; Mai BK
    Phys Chem Chem Phys; 2022 Dec; 24(48):29266-29278. PubMed ID: 36449268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.
    Paciaroni A; Libera V; Ripanti F; Orecchini A; Petrillo C; Francisci D; Schiaroli E; Sabbatini S; Gidari A; Bianconi E; Macchiarulo A; Hussain R; Silvestrini L; Moretti P; Belhaj N; Vercelli M; Roque Y; Mariani P; Comez L; Spinozzi F
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M
    Kakhar Umar A; Zothantluanga JH; Luckanagul JA; Limpikirati P; Sriwidodo S
    PeerJ; 2023; 11():e14915. PubMed ID: 36935912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
    Cetin A
    Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.